Confessions of a Bio-entrepreneur:The Nanopore Story with Gordon Sanghera

The Oxford Biotech Roundtable (OBR) and the Oxford Centre for Entrepreneurship and Innovation (OxCEI) present a talk by Gordon Sanghera,CEO of Oxford Nanopore.

About Gordon Sanghera

Gordon Sanghera was co-founder of Oxford Nanopore, together with Hagan Bayley and IP Group. He was appointed CEO in June 2005, having acted as a consultant since February 2005 whilst the company was established. He brings over 15 years experience in the design, development and global launch of novel point-of-care biosensor devices.

After nearly £90 million raised... Dr. Sanghera shares the secret behind Nanopore's fantastic rise.

About Oxford Nanopore

Oxford Nanopore Technologies was spun out from the University of Oxford in 2005. Oxford Nanopore employs a team of 100 people including scientists, engineers and informaticians based mainly at its headquarters in Oxford, UK. To date, the Company has raised nearly £75 million in six rounds of private funding, from a combination of private and institutional investors. Oxford Nanopore has a broad patent portfolio, through in-house development and licensing agreements with third parties.  The Company has licensed or owns more than 300 patents and patent applications that cover all aspects of nanopore sensing including fundamental patents for nanopore sensing, and patents relating to DNA sequencing.